Mechanism of ferroptosis resistance in cancer cells
Authors:
Open Access
- 20 November 2024
- journal article
- review article
- Published by OAE Publishing Inc. in Cancer Drug Resistance
- Vol. 7, 47
Abstract
Ferroptosis is an iron-dependent cell death characterized by increased intracellular lipid peroxidation. Inducing ferroptosis has shown significant potential in eliminating various malignancies. However, the effectiveness of ferroptosis-based treatments is hampered by the intrinsic or acquired resistance of some tumors. In this review, we delineate the known mechanisms that regulate ferroptosis sensitivity and summarize the therapeutic application of ferroptosis inducers in cancer. Additionally, we discuss the roles of diverse signaling pathways that contribute to ferroptosis resistance in cancer cells, including the glutathione (GSH) and coenzyme Q (CoQ) pathways, NFE2-like bZIP transcription factor 2 (NRF2) antioxidant response, and lipid and iron metabolism. This emerging knowledge may serve as a foundation for developing novel anticancer strategies to overcome ferroptosis resistance.Keywords
This publication has 159 references indexed in Scilit:
- PROM2 overexpression induces metastatic potential through epithelial‐to‐mesenchymal transition and ferroptosis resistance in human cancersClinical and Translational Medicine, 2024
- Induction of stearoyl‐CoA desaturase confers cell density‐dependent ferroptosis resistance in melanomaJournal of Cellular Biochemistry, 2024
- ATR‐dependent ubiquitin‐specific protease 20 phosphorylation confers oxaliplatin and ferroptosis resistanceMedcomm, 2023
- TRIM21‐Promoted FSP1 Plasma Membrane Translocation Confers Ferroptosis Resistance in Human CancersAdvanced Science, 2023
- Intracellular Delivery of Glutathione Peroxidase Degrader Induces Ferroptosis In VivoAngewandte Chemie International Edition, 2022
- The N6‐methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastomaClinical and Translational Medicine, 2022
- Metabolic Intervention Nanoparticles for Triple‐Negative Breast Cancer Therapy via Overcoming FSP1‐Mediated Ferroptosis ResistanceAdvanced Healthcare Materials, 2022
- Novel analogs of sulfasalazine as system xc− antiporter inhibitors: Insights from the molecular modeling studiesDrug Development Research, 2019
- Metallothionein‐1G facilitates sorafenib resistance through inhibition of ferroptosisHepatology, 2016
- Iron‐dependent cell death of hepatocellular carcinoma cells exposed to sorafenibInternational Journal of Cancer, 2013